The Role of Central Sensitization in Autoimmune Connective Tissue Diseases: A Comparative Cross‐Sectional Study
International Journal of Rheumatic Diseases · 2025-01 · 28 (1)
DOI: 10.1111/1756-185x.70069 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Journal of Rheumatic Diseases, online erschienen am 21.01.2025. Verfasst von Zilan Bazancir-Apaydin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiotherapy and Rehabilitation, Ankara Medipol University, Ankara, Türkiye. Hauptthemen laut MEDLINE: Sjogren's Syndrome, Lupus Erythematosus, Systemic, Arthritis, Rheumatoid, Autoimmunity. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
To investigate the central sensitization (CS) in patients with autoimmune connective tissue diseases (ACTDs) and its relationship with disease activity, laboratory findings, medical treatments, organ involvements, and comorbidity.
Methods
One hundred and eleven patients with ACTDs and 40 healthy individuals were included. All patients were divided into three groups in terms of their diseases: Sjögren's syndrome (SS), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE). The CS was assessed using the central sensitization inventory (CSI‐A and CSI‐B scores). The disease activity, laboratory findings, medical treatments, organ involvements, and comorbidity of all patients were evaluated.
Results
Overall, 41.4% patients with ACTDs had CS. SS group had the highest CS positivity ( n = 21, 58.3%) compared to the RA ( n = 14, 36.8%) and SLE ( n = 11, 29.7%) groups. The SS group had a significantly higher CSI‐A score ( p < 0.016) than the RA and SLE group, which had similar scores. CSI‐A ( p = 0.008, r = −0.63) and CSI‐B ( p = 0.001, r = −0.76) scores were moderately to high correlated with vitamin D3 levels in SLE group. CSI‐B score was moderately correlated with folic acid levels ( p = 0.03, r = 0.50) and TSH ( p = 0.005, r = 0.55) in SS group. The CSI‐A score ≥ 40 subgroup had more female gender, frequency of COPD or asthma, more coexisting fibromyalgia, higher VAS score, more common exocrine gland involvement, and higher corticosteroid dose compared to the CSI score < 40 subgroup.
Conclusions
CS is commonly seen in patients with ACTDs, especially in SS. CS is associated with vitamin D3, folic acid, and TSH levels in ACTD subgroups and the patients with clinical CS have a specific profile.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiotherapy and Rehabilitation, Ankara Medipol University, Ankara, Türkiye.
- Department of Rheumatology, Ankara Etlik City Hospital, Ankara, Türkiye.
- Department of Rheumatology, Ankara Bilkent City Hospital, Ankara, Türkiye.
ORCID-Profile: Zilan Bazancir-Apaydin, Berkan Armagan
Zitieren
APA
Bazancir-Apaydin, Z., Apaydin, H., Armagan, B., Orhan, K., & Erten, S. (2025). The Role of Central Sensitization in Autoimmune Connective Tissue Diseases: A Comparative Cross‐Sectional Study. International Journal of Rheumatic Diseases, 28(1). https://doi.org/10.1111/1756-185x.70069
Vancouver
Bazancir-Apaydin Z, Apaydin H, Armagan B, Orhan K, Erten S. The Role of Central Sensitization in Autoimmune Connective Tissue Diseases: A Comparative Cross‐Sectional Study. International Journal of Rheumatic Diseases. 2025;28(1). doi:10.1111/1756-185x.70069
BibTeX
@article{BazancirApaydin2025,
author = {Bazancir-Apaydin, Zilan and Apaydin, Hakan and Armagan, Berkan and Orhan, Kevser and Erten, Sukran},
title = {The Role of Central Sensitization in Autoimmune Connective Tissue Diseases: A Comparative Cross‐Sectional Study},
journal = {International Journal of Rheumatic Diseases},
year = {2025},
volume = {28},
number = {1},
doi = {10.1111/1756-185x.70069}
}
EUVIMED